Skip to main content

Canaan Partners — Portfolio, Page 8

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

269
Companies
$8.1B
Total invested
$39.5M
Avg. check
52
Industries
Artificial Intelligence (AI) 8Biotechnology 8Health Care 8Therapeutics 7Medical 5Information Technology 3+46 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 169–192 of 269
AttoTude
April 2025

AttoTude is a THz interconnect technology company using THz radios to enhance bandwidth for AI and hyperscale data centers.

Artificial Intelligence (AI) · Menlo Park$50.0M Series B
Page
March 2025

Page is an AI-powered external relations platform that provides real-time insights to help enterprises navigate government policies, media.

Artificial Intelligence (AI) · Toronto$2.9M Seed
Apex.AI
February 2025

Apex.AI specializes in software systems for robotic and autonomous vehicles.

Artificial Intelligence (AI) · Palo AltoSeries B
Valid
February 2025

The AI-enabled ad agency.

San Francisco$5.5M Seed
Neofin
February 2025

Neofin is a SaaS company that offers an AI-powered software for B2B payments workflows.

Artificial Intelligence (AI) · São Paulo$6.0M Seed
Aer Therapeutics
February 2025

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Biotechnology · Raleigh$5.0M Series Unknown
Reibus
January 2025

Reibus is a B2B marketplace for buying and selling metals that connects businesses and simplifies metal transactions.

B2B · AtlantaSeries B
Onkos Surgical
January 2025

Onkos Surgical is a surgical oncology company that develops implants and instruments for musculoskeletal tumor patients.

Health Care · Parsippany$30.0M Debt Financing
Enterpret
December 2024

Enterpret analyzes customer feedback using AI and NLP, offering tailored insights for product growth.

Analytics · San Francisco$20.8M Series A
Nivoda
November 2024

Nivoda is a digital marketplace and supply chain for natural and lab-grown diamonds.

Jewelry · London$51.0M Series C
Treehouse
October 2024

Treehouse is a software-enabled service for home electrification.

Clean Energy · San Francisco$16.6M Series A
Glooko
October 2024

Glooko as a digital health company that offers a diabetes management platform to help users monitor and control their blood glucose levels.

Diabetes · Palo Alto$100.0M Series F
Cashmere AI
September 2024

Cashmere AI is a platform that helps wealth firms find and contact prospects using AI-based financial event data.

Artificial Intelligence (AI) · Los Angeles$3.6M Seed
Halda Therapeutics
August 2024

Halda Therapeutics is a research-stage drug discovery company.

Biotechnology · New Haven$126.0M Series B
Cayena
July 2024

Cayena offers a B2B marketplace for restaurants to procure inventory from suppliers with next day delivery and better payment terms.

B2B · São Paulo$55.0M Series B
CatalYm
July 2024

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

Biotechnology · Planegg$150.0M Series D
IDEAYA Biosciences
July 2024

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Biotechnology · South San Francisco$263.0M Post Ipo Equity
Aim Security
June 2024

Aim Security is a GenAI security platform that aids enterprises in securing their transformation and increasing business productivity.

Artificial Intelligence (AI) · Tel Aviv$18.0M Series A
Qlaris Bio
April 2024

Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.

Biotechnology · Wellesley$24.0M Series B
Pathios Therapeutics
April 2024

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

Biotechnology · Oxford$25.0M Series B
Rallybio
April 2024

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Biopharma · Farmington$6.6M Post Ipo Equity
Binarly
March 2024

Binarly is the most advanced automated AI/ML supply chain security platform to identify vulnerabilities in firmware and software components

Artificial Intelligence (AI) · Santa Monica$10.5M Seed
Ottopay
March 2024

Otto is an Intelligent and automated debt payments.

FinTech · Los AngelesSeed
Tyra Biosciences
February 2024

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Biotechnology · Carlsbad$200.0M Post Ipo Equity

Where Canaan Partners invests

Artificial Intelligence (AI)8
Biotechnology8
Health Care8
Therapeutics7
Medical5
Information Technology3

About Canaan Partners's portfolio

How many companies has Canaan Partners invested in?▸

Canaan Partners has invested in 269 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Canaan Partners invest in?▸

Canaan Partners's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics, Medical. The firm invests across 52 different industry categories.

What is Canaan Partners's largest investment?▸

Among tracked funding rounds, IDEAYA Biosciences received $263.0M in a Post Ipo Equity round. Canaan Partners's total known invested capital is $8.1B.

What is the average investment size for Canaan Partners?▸

Canaan Partners's average investment size is $39.5M across its portfolio of 269 companies.

What are Canaan Partners's most recent investments?▸

Recent Canaan Partners portfolio additions include AttoTude, Page, Apex.AI, Valid, Neofin. These companies were founded in 2020 or later.

Reach the founders behind these 269 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →